Delivery of ciliary neurotrophic factor via lentiviral-mediated transfer protects axotomized retinal ganglion cells for an extended period of time.
about
CNTF and retinaRetinal degeneration progression changes lentiviral vector cell targeting in the retinaEffect of CNTF on retinal ganglion cell survival in experimental glaucomaImpediments to eye transplantation: ocular viability following optic-nerve transection or enucleationIn vivo gene delivery in the retina using polyethylenimineProliferating brain cells are a target of neurotoxic CSF in systemic autoimmune disease.Gene therapy for ocular diseasesRepublished review: Gene therapy for ocular diseases.Study on establishment and mechanics application of finite element model of bovine eye.Optic nerve and neuroprotection strategies.Prospectives for gene therapy of retinal degenerationsApplication of encapsulated cell technology for retinal degenerative diseases.Gene therapy progress and prospects: the eye.Rewiring the injured CNS: lessons from the optic nerve.Nonviral ocular gene therapy: assessment and future directions.CNTF-mediated protection of photoreceptors requires initial activation of the cytokine receptor gp130 in Müller glial cells.Gene therapy for retinal ganglion cell neuroprotection in glaucoma.Ocular gene delivery using lentiviral vectors.Challenges in neuroprotective nanomedicine development: progress towards noninvasive gene therapy of glaucoma.Gene therapy in animal models of autosomal dominant retinitis pigmentosaNeuroprotective therapies in glaucoma: I. Neurotrophic factor delivery.Methods for experimental manipulations after optic nerve transection in the Mammalian CNS.Protective effects of human umbilical cord blood stem cell intravitreal transplantation against optic nerve injury in rats.Potentiation of in vivo neuroprotection by BclX(L) and GDNF co-expression depends on post-lesion time in deafferentiated CNS neurons.Effect of GDNF gene transfer into axotomized retinal ganglion cells using in vivo electroporation with a contact lens-type electrode.Reduced retinal transduction and enhanced transgene-directed immunogenicity with intravitreal delivery of rAAV following posterior vitrectomy in dogs.Clinical Considerations for Vascularized Composite Allotransplantation of the Eye.Expression of ciliary neurotrophic factor (CNTF) and its tripartite receptor complex by cells of the human optic nerve head.AAV-mediated expression of CNTF promotes long-term survival and regeneration of adult rat retinal ganglion cells.STAT3 activation in photoreceptors by leukemia inhibitory factor is associated with protection from light damage.Synergistic action of brain-derived neurotrophic factor and lens injury promotes retinal ganglion cell survival, but leads to optic nerve dystrophy in vivo.Ciliary neurotrophic factor (CNTF) delivery to retina: an overview of current research advancements.
P2860
Q28731691-7B28C993-279B-495C-9A28-73ACC9FD69B3Q28741007-4B0BC4FE-DDA3-43AB-957E-E85365C76AA2Q33390314-8F510D02-8345-496C-96C9-E3D451F6FC83Q33772519-0B0CC079-5785-482B-B62C-9DC65325EB63Q33914306-C22D480D-3BDF-409D-A991-9934D348F002Q35126686-B3BF419C-9D10-4A0B-BC9F-3E8F33659555Q35160142-380DA336-1117-4C5D-80C3-7572F2D4CB63Q35210756-8032C253-4FF2-499E-A705-584394EF005EQ35744346-F002610E-A270-469C-A03D-290CFF79242AQ35944015-70BD8581-450D-49BE-9CEE-D5956830AD29Q36108106-4822FC1C-AD80-4630-A7AF-D60F601BF187Q36521847-21544035-9C91-4F0D-B8A1-B16D7C00A30EQ36534765-1B9D6AE4-6AD3-4E30-BBDC-6FEA29E90224Q36870250-3DEC7C4F-3E1C-4181-842B-1CA7C2F19961Q37284890-DB44CB83-B7BD-4E04-BA96-81AF5B5FFD9DQ37340676-D6DD7063-9021-4BF9-AD32-6A497CEC8F27Q37942753-50F1DEA5-1CDE-448D-BAE8-1FA329F1278CQ37952564-BAF149CA-D1C6-473D-A1D3-CBD943583556Q38030642-498037A6-51EC-4096-BACD-CDB8362D93D9Q38053151-B5D5A9C3-109D-4D4E-8B09-F20BEEE28BB1Q38573732-13594BD3-1E2B-4C34-B3E1-79F04EC7843EQ38759012-E81D1CBF-D33F-4512-AA4D-7037A29EB497Q39584385-676FE64C-B3B9-45BD-B7D8-67EA4945653BQ40256223-AC138444-3F98-4BAA-BB68-1FC7C7C31A64Q40477606-A8BA2DE6-99C7-4352-82C7-B845D4FDC2CFQ40814049-6746E368-088B-4F02-A0BE-221A2793AAE0Q41647397-2943C559-3A33-46A2-B3C3-AD8869562650Q42265340-83EF97D3-1FFD-4BA4-BA6C-9E0B89B42063Q45858441-8C889F78-338A-47B5-8632-61980F79287AQ46844274-233CB17E-AD18-4212-A12D-C68426CFFB25Q46897884-277D4128-0660-44C9-BE45-B3C116F42CD4Q47601916-E2A41704-1509-4505-8B82-A92F088FD8AC
P2860
Delivery of ciliary neurotrophic factor via lentiviral-mediated transfer protects axotomized retinal ganglion cells for an extended period of time.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Delivery of ciliary neurotroph ...... or an extended period of time.
@en
Delivery of ciliary neurotroph ...... or an extended period of time.
@nl
type
label
Delivery of ciliary neurotroph ...... or an extended period of time.
@en
Delivery of ciliary neurotroph ...... or an extended period of time.
@nl
prefLabel
Delivery of ciliary neurotroph ...... or an extended period of time.
@en
Delivery of ciliary neurotroph ...... or an extended period of time.
@nl
P2093
P1433
P1476
Delivery of ciliary neurotroph ...... or an extended period of time.
@en
P2093
Alexander K Ball
Brian A van Adel
Yvan Arsenijevic
P304
P356
10.1089/104303403321070801
P577
2003-01-01T00:00:00Z